Eric Bouffet
Hospital of Sick Children · The Hospital for Sick Children · The Hospital for Sick Children, Toronto Canada
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Eric Bouffet as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:56 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06362434 · Visual Telerehabilitation in Children, Adolescents and Young Adults With Hemianopsia Consecutive to a Brain TumourUniversity Health Network, Toronto · not yet recruiting · Hemianopsia · principal investigator
- Ph3NCT05230758 · Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain TumourDonald Mabbott · recruiting · Medulloblastoma, Childhood, Cognitive Impairment · principal investigator
- Ph1NCT03206021 · COZMOS:Phase I/Ib Trial of Combined 5'Azacitidine and Carboplatin for Recurrent/Refractory Pediatric Brain/Solid TumorsThe Hospital for Sick Children · completed · Recurrent Childhood CNS Tumor, Ependymoma, Recurrent Childhood, Childhood Solid Tumor · principal investigator
- Ph2NCT02840409 · Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG)The Hospital for Sick Children · unknown · Low Grade Glioma · principal investigator
- Ph2NCT00600054 · Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine GliomaYM BioSciences · completed · Recurrent Diffuse Pontine Gliomas · principal investigator
- Ph1NCT00352495 · Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade GliomaChildren's Oncology Group · completed · Brain and Central Nervous System Tumors, Neurofibromatosis Type 1 · study chair
- Ph2NCT00213278 · Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade GliomaThe Hospital for Sick Children · completed · Glioma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:56 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in medulloblastoma, ranked by citations from NIH iCite, fetched 2026-11-12 11:56 UTC. The ranking covers the 200 most relevant of 15 PubMed records, and a shared surname and initials can bring in a namesake. All 15 on PubMed
- Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).J Clin Oncol · 2021201 citationsRCR 11.3
- Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma.Neuro Oncol · 2017149 citationsRCR 4.5
- Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients?Neuro Oncol · 2016110 citationsRCR 3.5
- Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours.Eur J Cancer · 200668 citationsRCR 1.7
- Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma.Neuro Oncol · 201466 citationsRCR 2.5
- Phase II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children Younger Than 4 Years of Age: A Report of the Children's Oncology Group (ACNS1221).J Clin Oncol · 202065 citationsRCR 2.8
- 64 citationsRCR 2.4
- Improving survival in recurrent medulloblastoma: earlier detection, better treatment or still an impasse?Br J Cancer · 199861 citationsRCR 1.4
- M4 protocol for cerebellar medulloblastoma: supratentorial radiotherapy may not be avoided.Int J Radiat Oncol Biol Phys · 199252 citationsRCR 1.8
- Carboplatin and VP 16 in medulloblastoma: a phase II Study of the French Society of Pediatric Oncology (SFOP).Med Pediatr Oncol · 199447 citationsRCR 1.7